+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zeclar"

Zeclar - API Insight, 2022 - Product Thumbnail Image

Zeclar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zeclar- Drug Insight, 2019 - Product Thumbnail Image

Zeclar- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Zeclar is an antibiotic drug used to treat a variety of bacterial infections. It belongs to a class of antibiotics known as macrolides, which work by inhibiting the growth of bacteria. Zeclar is commonly used to treat respiratory tract infections, skin infections, and urinary tract infections. It is also used to prevent certain types of bacterial infections in people who are at risk of developing them. Zeclar is available in both oral and intravenous forms. The Zeclar market is highly competitive, with a number of companies offering the drug. Some of the major players in the market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and AstraZeneca. These companies are engaged in the development, manufacturing, and marketing of Zeclar. They are also involved in research and development activities to improve the efficacy and safety of the drug. Show Less Read more